Upregulation of Ornithine Decarboxylase mRNA Expression in Barrett's Esophagus and Barrett's-Associated Adenocarcinoma

Journal of Gastrointestinal Surgery

Volumn 5, Issue 2, 2001, Pages 174-182

  Brabender, Jan ^a,b   Lord, Reginald V ^a   Danenberg, Kathleen D ^a   Metzger, Ralf ^b   Schneider, Paul M ^b   Uetake, Hiroyuki ^a   Kawakami, Kazuyuki ^a   Park, Ji Min ^a   Salonga, Dennis ^a   Peters, Jeffrey H ^a   DeMeester, Tom R ^a   Hölscher, Arnulf H ^b   Danenberg, Peter V ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; Esophageal neoplasia; ODC; Ornithine decarboxylase

Indexed keywords

MESSENGER RNA; ORNITHINE DECARBOXYLASE; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; ORNITHINE DECARBOXYLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 18044404506     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(01)80031-7     Document Type: Article

References (43)

1. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315:362-371.
2. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-993.
3. Cameron AJ, Lomboy CT. Barrett's esophagus: Age, prevalence, and extent of the columnar epithelium. Gastroenterology 1992;103:1241-1245.
4. Williamson WA, Ellis FH, Gibb SP, Shanian DN, Aretz HT, Heady GJ, Watkins E. Barrett's esophagus: Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991;151:2212-2216.
5. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopie surveillance of a cohort. Gastroenterology 1992;102:1212-1219.
6. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999;26:2-8.
7. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104: 510-513.
8. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
9. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50.
10. DeMeester TR. Surgical treatment of dysplasia and adenocarcinoma. Gastroenterol Clin North Am 1997;26:669-684.
11. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-178.
12. Pegg AE, McCann PP. Polyamine metabolism and function. Am J Physiol 1982;243:C212-C221.
13. Steglich C, Grens A, Scheffler IE. Chinese hamster cells deficient in ornithine decarboxylase activity: Reversion by gene amplification and by azacytidine treatment. Somat Cell Mol Genet 1985;11:11-23.
14. Pohjanpelto P, Hötta E, Jänne OA. Mutant strain of Chinese hamster ovary cells with no detectable ornithine decarboxylase activity. Mol Cell Biol 1985;5:1385-1390.
15. Hirvonen A. Ornithine decarboxylase activity and the accumulation of its mRNA during early stages of liver regeneration. Biochem Biophys Acta 1989;1007:120-123.
16. Beyer HS, Zieve L. Effects of partial and sham hepatectomy on ornithine decarboxylase and thymidine kinase activities and mRNA contents. Biochem Int 1990;20:761-765.
17. Tabor CW, Tabor H. Polyamines. Annu Rev Biochem 1984; 53:749-790.
18. Pegg AE. Recent advances in the biochemistry of polyamines in eukaryotes. 1986;234:2249-2262.
19. Heby O, Persson L. Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci 1990;172:153-158.
20. Yuspa SH, Lichti U, Ben T, Patterson E, Hennings H, Slaga TJ, Colburn N, Kelsey W. Phorbol esters stimulate DNA synthesis and ornithine decarboxylase activity in mouse epidermal cell cultures. Nature 1976;262:402-404.
21. Gilmour SK, Verma AK, Madara T, O'Brien TG. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage carcinogenesis. Cancer Res 1987;47:1221-1225.
22. Don S, Bachrach U. Polyamine metabolism in normal and in virus-transformed chick embryo fibroblasts. Cancer Res 1975; 35:3618-3622.
23. Gazdar AF, Stull HB, Kilton LJ, Bachrach U. Increased ornithine decarboxylase activity in murine sarcoma virus infected cells. Nature 1976;262:696-698.
24. Hötta E, Sistonen L, Alitalo K. The mechanism of ornithine decarboxylase deregulation in c-Ha-ras 19 oncogene-transformed NIH 3T3 cells. J Biol Chem 1988;263:4500-4507.
25. Hibshoosh H, Johnson M, Weinstein IB. Effects of overexpression of ornithine decarboxylase on growth control and oncogene induced cell transformation. Oncogene 1991;6:739-743.
26. Auvinen M, Paasinen A, Anderson LC, Hötta E. Ornithine decarboxylase activity is critical for cell transformation. Nature 1992;360:355-358.
27. Shantz LM, Pegg AE. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res 1994;54: 2313-2316.
28. Hietala OA, Yum KY, Pilon J, O'Donell K, Holroyde CP, Kline I, Reichard GA, Litwin S, Gilmour SK, O'Brien TG. Properties of ornithine decarboxylase in human colorectal adenocarcinoma. Cancer Res 1990;50:2088-2094.
29. Okuzumi J, Yamane T, Kitano Y, Tokiwa K, Yamaguchi T, Fujita Y, Nishino H, Iwashima A, Takahashi T. Increased mucosal ornithine decarboxylase activity in human gastric cancers. Cancer Res 1991;51:1448-1451.
30. Yoshida M, Hayashi H, Taira M, Isono M. Elevated expression of ornithine decarboxylase gene in human esophageal cancer. Cancer Res 1992;52:6671-6675.
31. Garewal HS, Sampliner R, Gerner E, Steinbronn K, Alberts D, Kendall D. Ornithine decarboxylase levels in Barrett's esophagus: A potential marker for dysplasia. Gastroenterology 1988;94:819-821.
32. Garewal HS, Gerner EW, Sampliner RE, Roe DW. Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosae in patients with Barrett's esophagus. Cancer Res 1988;48:3288-3291.
33. Garewal HS, Sampliner R, Barrett's esophagus: A model premalignant lesions for adenocarcinoma. Prev Med 1989;18: 749-756.
34. Garewal HS, Sampliner RE, Fennerty B. Chemopreventive studies in Barrett's esophagus: A model premalignant lesion for esophageal carcinoma. J Nad Cancer Inst Monogr 1992; 13:51-54.
35. Gerner W, Garewal HS, Emerson SS, Sampliner RE. Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine. Cancer Epidemiol Biomarkers Prev 1994;4:325-330.
36. Garewal HS, Ramsey LR, Sharma P, Kraus K, Sampliner R, Fass R. Biomarker studies in reversed Barrett's esophagus. Am J Gastroenterol 1999;94:2829-2833.
37. Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM, Johansson J, Skinner KA, Chandrasoma P, DeMeester SR, Bremner CG, Tsai PI, Danenberg PV. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, carcinoma sequence. J GASTROINTEST SURG 2000;4:135-142.
38. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-994.
39. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res 1996;6:995-1001.
40. Garewal HS, Sampliner R, Alberts D, Steinbronn K. Increase in ornithine decarboxylase activity associated with development of dysplasia in Barrett's esophagus. Dig Dis Sci 1989; 34:312-314.
41. Mafune K, Tanaka Y, Mimori K, Mori M, Takubo K, Makuuchi M. Increased expression of onithine decarboxylase mRNA in human esophageal carcinoma. Clin Cancer Res. 1999;5:4073-4078.
42. Tsai PI, Danenberg K, Lord RV, Peters JH, DeMeester TR, Bremner CJ, Salonga D, Park JM, Kiyabu M, Crookes P, Hagen J, DeMeester SR, Singer J, Danenberg PV. Retinoic acid receptor expression in Barrett's esophagus and Barrett's associated adenocarcinomas. Proc Annu Meet Am Assoc Cancer Res 1999;40:A2053.
43. Clifford A, Morgan D, Yuspa SH, Soler AP, Gilmour S. Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res 1995;55:1680-1686.